Franklin Street Advisors’s PDL BioPharma, Inc. PDLI Stock Holding History

Franklin Street Advisors’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-20,000	Closed	-$53K	–	167
2018 Q3	$53K	Hold	20,000	–	–	0.01%	157
2018 Q2	$47K	Hold	20,000	–	–	0.01%	157
2018 Q1	$59K	Hold	20,000	–	–	0.01%	162
2017 Q4	$55K	Sell	20,000 -2,500	-11%	-$7.68K	0.01%	164
2017 Q3	$76K	Hold	22,500	–	–	0.01%	153
2017 Q2	$56K	Hold	22,500	–	–	0.01%	146
2017 Q1	$51K	Hold	22,500	–	–	0.01%	156
2016 Q4	$48K	Hold	22,500	–	–	0.01%	169
2016 Q3	$75K	Sell	22,500 -15,000	-40%	-$47.6K	0.01%	175
2016 Q2	$118K	Sell	37,500 -2,500	-6%	-$8.34K	0.02%	191
2016 Q1	$133K	Buy	40,000 +2,500	+7%	+$7.79K	0.03%	212
2015 Q4	$133K	Hold	37,500	–	–	0.03%	214
2015 Q3	$189K	Hold	37,500	–	–	0.04%	208
2015 Q2	$241K	Hold	37,500	–	–	0.04%	198
2015 Q1	$264K	Hold	37,500	–	–	0.05%	183
2014 Q4	$289K	Hold	37,500	–	–	0.06%	168
2014 Q3	$280K	Hold	37,500	–	–	0.05%	198
2014 Q2	$363K	Hold	37,500	–	–	0.07%	174
2014 Q1	$312K	Hold	37,500	–	–	0.06%	193
2013 Q4	$316K	Hold	37,500	–	–	0.06%	201
2013 Q3	$299K	Hold	37,500	–	–	0.07%	199
2013 Q2	$289K	Buy	+37,500	New	+$292K	0.07%	204

Other funds holding PDLI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Franklin Street Advisors's PDLI Position: Q4 2018 in Review

Franklin Street Advisors sold out of PDL BioPharma, Inc. (PDLI) in Q4 2018, closing a stake of 20,000 shares — an estimated $53K sold.

Franklin Street Advisors first reported a position in PDLI in Q2 2013 and held it in 22 quarters. The position peaked at $363K in Q2 2014. 154 funds tracked by Wall St. Rank hold PDLI as of Q4 2018.

Franklin Street Advisors reported no remaining PDL BioPharma, Inc. position as of Q4 2018 after selling out during the quarter.
Franklin Street Advisors sold 20,000 PDL BioPharma, Inc. shares in Q4 2018, an estimated $53K.
Franklin Street Advisors first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 22 quarters.
Franklin Street Advisors's PDL BioPharma, Inc. position peaked at $363K in Q2 2014.
154 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2018.

Based on Franklin Street Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.